Berlin, Germany – Today, March 4th, is World Obesity Day, a crucial moment to address a growing global health crisis. In Sweden, like many nations, obesity is no longer simply a health risk, but a widespread public health challenge affecting over half of the adult population. This year’s theme, “8 billion reasons to act against obesity,” underscores the urgent need for collective responsibility and comprehensive interventions. While medical advancements offer modern hope, significant disparities in access to care within Sweden are raising concerns among healthcare professionals and patient advocacy groups.
The rising prevalence of obesity is a complex issue, driven by a confluence of factors including lifestyle changes, socioeconomic conditions, and increasingly obesogenic environments. According to the Folkhälsomyndigheten (Public Health Agency of Sweden), more than half of the adult population in Sweden now lives with overweight or obesity, a trend that has been consistently increasing since 1980. The agency highlights that these changes are largely attributable to shifts in people’s physical and social environments, rather than individual failings.
This growing concern has prompted calls for systemic change, with a recent debate article in Aftonbladet, signed by representatives from 16 organizations, urging the Swedish government to ensure equitable access to obesity care across the country. The signatories, including leaders from Forska Sverige (Research Sweden), Lif – the research-based pharmaceutical companies, Apotekarsocieteten (The Swedish Pharmacists’ Association), and Sveriges Farmaceuter (Swedish Pharmacists’ Association), argue that current disparities are unacceptable and hinder effective treatment.
The Disparities in Obesity Care Across Sweden
One of the core issues highlighted by the advocacy groups is the uneven distribution of specialized care units for both children and adults with obesity. Socialstyrelsen (the Swedish Health and Social Care Inspectorate) guidelines recommend specialized services, but their availability varies significantly between regions. Some regions have established dedicated units, while others lack these crucial resources, creating a postcode lottery for patients seeking comprehensive care. This lack of standardization extends to the content of treatment programs and the follow-up care provided after interventions like bariatric surgery.
The disparities are starkly illustrated by follow-up care data. According to figures cited in Svensk Farmaci, nearly 93% of patients in one region received follow-up care two years after undergoing obesity surgery in 2025, while in another region, that figure was below 17%. This significant difference in post-operative care can have a profound impact on long-term outcomes and patient well-being. The lack of consistent follow-up can lead to complications, reduced adherence to lifestyle changes, and poorer health outcomes.
These inequalities aren’t simply about access to specialized units. they also reflect differences in the overall approach to obesity management. Some regions prioritize preventative measures and early intervention, while others focus primarily on treating advanced cases. This fragmented approach hinders a coordinated national strategy to combat the obesity epidemic.
Advancements in Treatment and the Need for Wider Access
Despite the challenges in access to care, significant progress has been made in obesity treatment in recent years. The development of appetite-suppressing medications, such as Wegovy, has revolutionized the therapeutic landscape, offering patients a powerful tool to manage their weight. Advancements in surgical techniques have improved the safety and effectiveness of bariatric surgery, enabling more individuals to achieve long-term weight loss and improved health. However, the benefits of these advancements are not being equitably distributed.
The debate surrounding access to newer medications like Wegovy is particularly contentious. The Tandvårds- och läkemedelsförmånsverket (TLV – the Dental and Pharmaceutical Benefits Agency) has faced criticism for its decisions regarding the reimbursement of these drugs, with some arguing that its assessments are overly restrictive and limit access for patients who could benefit. As reported by Svensk Farmaci, concerns have been raised that the TLV’s decisions represent a missed opportunity for Sweden to improve obesity care.
The call for equitable access extends beyond medication. Comprehensive obesity care should include lifestyle interventions, nutritional counseling, psychological support, and regular monitoring. However, these services are often underfunded and unavailable in many parts of the country, particularly in rural areas.
The Role of Research and Investment
Addressing the obesity crisis requires a sustained commitment to research and innovation. The debate article in Aftonbladet emphasizes the need for increased investment in medical research focused on obesity and related conditions. Currently, government investment in health-related medical research represents less than 1.5 öre per healthcare krona. The signatories are urging the government and parliament to increase this investment to four öre per healthcare krona, arguing that this would significantly accelerate the development of new treatments and preventative strategies.
Further research is needed to understand the complex interplay of genetic, environmental, and behavioral factors that contribute to obesity. This knowledge will be crucial for developing targeted interventions that address the specific needs of different populations. Research is needed to evaluate the effectiveness of different treatment approaches and to identify best practices for obesity management.
The Broader Societal Context
The Folkhälsomyndigheten emphasizes that addressing obesity requires a broader societal approach that goes beyond individual responsibility. The agency’s World Obesity Day campaign, themed “8 billion reasons to act against obesity,” highlights the need for collective action and shared responsibility. Creating healthier environments that promote physical activity and healthy eating is essential. This includes policies that support access to affordable, nutritious food, promote active transportation, and limit the marketing of unhealthy products.
The agency points to changes in our environment – including digitalization, product development, and product placement – as key drivers of the obesity epidemic. These changes have shaped new societal norms that often prioritize convenience and consumption over health. Reversing this trend requires a fundamental shift in our approach to urban planning, food systems, and public health messaging.
More than half of the adult population in Sweden lives with overweight or obesity.
Socialstyrelsen is currently undertaking an evaluation of obesity care in Sweden and analyzing the use of obesity medications, a crucial step towards identifying areas for improvement and developing evidence-based guidelines. This evaluation is expected to inform future policy decisions and resource allocation.
The challenges surrounding obesity care in Sweden are multifaceted, requiring a coordinated and sustained effort from policymakers, healthcare professionals, researchers, and the public. Addressing these challenges is not only a matter of public health, but also of social justice, ensuring that all individuals have the opportunity to live healthy and fulfilling lives.
The next key development to watch is the release of Socialstyrelsen’s evaluation of obesity care, expected later in 2026. This report will likely provide valuable insights into the current state of obesity care in Sweden and inform future policy decisions. We encourage readers to share their experiences with obesity care in Sweden and to engage in the ongoing conversation about how to improve access to effective treatment and support.
Worth a look